Disclosing the CXCR4 Expression in Lymphoproliferative Diseases by Targeted Molecular Imaging

被引:168
作者
Wester, Hans Juergen [1 ]
Keller, Ulrich [2 ]
Schottelius, Margret [1 ]
Beer, Ambros [3 ]
Philipp-Abbrederis, Kathrin [2 ]
Hoffmann, Frauke [1 ]
Simecek, Jakub [1 ]
Gerngross, Carlos [3 ]
Lassmann, Michael [4 ]
Herrmann, Ken [4 ]
Pellegata, Natalia [5 ]
Rudelius, Martina [6 ]
Kessler, Horst [7 ,8 ]
Schwaiger, Markus [3 ]
机构
[1] Tech Univ Munich, Pharmaceut Radiochem, Garching, Germany
[2] Tech Univ Munich, Dept Med 3, D-80290 Munich, Germany
[3] Tech Univ Munich, Dept Nucl Med, D-80290 Munich, Germany
[4] Univ Hosp Wurzburg, Dept Nucl Med, Wurzburg, Germany
[5] Helmholtz Zentrum Munchen, Inst Pathol, Munich, Germany
[6] Univ Wurzburg, Inst Pathol, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany
[7] Tech Univ Munich, Dept Chem, Inst Adv Study, Garching, Germany
[8] King Abdulaziz Univ, Fac Sci, Dept Chem, Jeddah, Saudi Arabia
关键词
CXCR4; chemokine receptor; positron emission tomography; lymphoma; in vivo imaging; CHEMOKINE RECEPTOR CXCR4; HUMAN CANCER XENOGRAFTS; B-CELL LYMPHOMA; ANTAGONIST PLERIXAFOR; RADIATION-DOSIMETRY; PROGNOSTIC VALUE; POOR SURVIVAL; IN-VITRO; PET; PEPTIDES;
D O I
10.7150/thno.11251
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Chemokine ligand-receptor interactions play a pivotal role in cell attraction and cellular trafficking, both in normal tissue homeostasis and in disease. In cancer, chemokine receptor-4 (CXCR4) expression is an adverse prognostic factor. Early clinical studies suggest that targeting CXCR4 with suitable high-affinity antagonists might be a novel means for therapy. In addition to the preclinical evaluation of [Ga-68]Pentixafor in mice bearing human lymphoma xenografts as an exemplary CXCR4-expressing tumor entity, we report on the first clinical applications of [Ga-68]Pentixafor-Positron Emission Tomography as a powerful method for CXCR4 imaging in cancer patients. [Ga-68]Pentixafor binds with high affinity and selectivity to human CXCR4 and exhibits a favorable dosimetry. [Ga-68]Pentixafor-PET provides images with excellent specificity and contrast. This non-invasive imaging technology for quantitative assessment of CXCR4 expression allows to further elucidate the role of CXCR4/CXCL12 ligand interaction in the pathogenesis and treatment of cancer, cardiovascular diseases and autoimmune and inflammatory disorders.
引用
收藏
页码:618 / 630
页数:13
相关论文
共 80 条
[31]   Inhibitors of CXC chemokine receptor type 4: putative therapeutic approaches in inflammatory diseases [J].
Hummel, Stephanie ;
Van Aken, Hugo ;
Zarbock, Alexander .
CURRENT OPINION IN HEMATOLOGY, 2014, 21 (01) :29-36
[32]   CXCR4 Chemokine Receptor Overview: Biology, Pathology and Applications in Imaging and Therapy [J].
Jacobson, Orit ;
Weiss, Ido Dov .
THERANOSTICS, 2013, 3 (01) :1-2
[33]   Improvement of CXCR4 tracer specificity for PET imaging [J].
Jacobson, Orit ;
Weiss, Ido D. ;
Szajek, Lawrence P. ;
Niu, Gang ;
Ma, Ying ;
Kiesewetter, Dale O. ;
Peled, Amnon ;
Eden, Henry S. ;
Farber, Joshua M. ;
Chen, Xiaoyuan .
JOURNAL OF CONTROLLED RELEASE, 2012, 157 (02) :216-223
[34]   PET imaging of CXCR4 using copper-64 labeled peptide antagonist [J].
Jacobson, Orit ;
Weiss, Ido D. ;
Szajek, Lawrence P. ;
Niu, Gang ;
Ma, Ying ;
Kiesewetter, Dale O. ;
Farber, Joshua M. ;
Chen, Xiaoyuan .
THERANOSTICS, 2011, 1 :251-262
[35]  
Jacobson O, 2010, J NUCL MED, V51, P1796, DOI 10.2967/jnumed.110.079418
[36]   64Cu-AMD3100-A novel imaging agent for targeting chemokine receptor CXCR4 [J].
Jacobson, Orit ;
Weiss, Ido D. ;
Szajek, Lawrence ;
Farber, Joshua M. ;
Kiesewetter, Dale O. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (04) :1486-1493
[37]  
James ML, 2012, PHYSIOL REV, V92, P997
[38]   Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: An independent prognostic factor for tumor progression [J].
Jiang, Yu-ping ;
Wu, Xiao-hua ;
Shi, Bin ;
Wu, Wen-xin ;
Yin, Gui-ran .
GYNECOLOGIC ONCOLOGY, 2006, 103 (01) :226-233
[39]   CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survival [J].
Jose Moreno, Maria ;
Bosch, Rosa ;
Dieguez-Gonzalez, Rebeca ;
Novelli, Silvana ;
Mozos, Ana ;
Gallardo, Alberto ;
Angel Pavon, Miguel ;
Virtudes Cespedes, Maria ;
Granena, Albert ;
Alcoceba, Miguel ;
Blanco, Oscar ;
Gonzalez-Diaz, Marcos ;
Sierra, Jorge ;
Mangues, Ramon ;
Casanova, Isolda .
JOURNAL OF PATHOLOGY, 2015, 235 (03) :445-455
[40]   Stromal Cell-Derived Factor-1 Retention and Cardioprotection for Ischemic Myocardium [J].
Kanki, Sachiko ;
Segers, Vincent F. M. ;
Wu, Weitao ;
Kakkar, Rahul ;
Gannon, Joseph ;
Sys, Stanislas U. ;
Sandrasagra, Anthony ;
Lee, Richard T. .
CIRCULATION-HEART FAILURE, 2011, 4 (04) :509-+